Cardiac characteristics and natural progression in Taiwanese patients with mucopolysaccharidosis III

被引:14
作者
Lin, Hsiang-Yu [1 ,2 ,3 ,4 ,5 ,6 ]
Chen, Ming-Ren [1 ,2 ,4 ]
Lin, Shan-Miao [1 ,2 ,4 ]
Hung, Chung-Lieh [1 ,7 ]
Niu, Dau-Ming [8 ]
Chang, Tung-Ming [9 ,10 ]
Chuang, Chih-Kuang [3 ,11 ]
Lin, Shuan-Pei [1 ,2 ,3 ,12 ]
机构
[1] Mackay Med Coll, Dept Med, New Taipei, Taiwan
[2] Mackay Mem Hosp, Dept Pediat, 92,Sec 2,Chung Shan North Rd, Taipei 10449, Taiwan
[3] Mackay Mem Hosp, Dept Med Res, 92 Chung Shan N Rd,Sec 2, Taipei 10449, Taiwan
[4] Mackay Jr Coll Med Nursing & Management, Taipei, Taiwan
[5] China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung, Taiwan
[6] Mackay Med Coll, Inst Biomed Sci, New Taipei, Taiwan
[7] Mackay Mem Hosp, Div Cardiol, Dept Internal Med, Taipei, Taiwan
[8] Taipei Vet Gen Hosp, Dept Pediat, Taipei, Taiwan
[9] Changhua Christian Childrens Hosp, Dept Pediat Neurol, Changhua, Taiwan
[10] Natl Chiao Tung Univ, Coll Biol Sci & Technol, Dept Biol Sci & Technol, Hsinchu, Taiwan
[11] Fu Jen Catholic Univ, Coll Med, Taipei, Taiwan
[12] Natl Taipei Univ Nursing & Hlth Sci, Dept Infant & Child Care, Taipei, Taiwan
关键词
Cardiac; Echocardiography; Electrocardiography; Mucopolysaccharidosis III; Valvular heart disease; ENZYME-REPLACEMENT THERAPY; CARDIOVASCULAR CHANGES; EUROPEAN-ASSOCIATION; ECHOCARDIOGRAPHIC-ASSESSMENT; CHAMBER QUANTIFICATION; AMERICAN-SOCIETY; RECOMMENDATIONS; CHILDREN; SANFILIPPO; MORTALITY;
D O I
10.1186/s13023-019-1112-7
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
BackgroundMucopolysaccharidosis type III (MPS III), or Sanfilippo syndrome, is caused by a deficiency in one of the four enzymes involved in the lysosomal degradation of heparan sulfate. Cardiac abnormalities have been observed in patients with all types of MPS except MPS IX, however few studies have focused on cardiac alterations in patients with MPS III.MethodsWe reviewed medical records, echocardiograms, and electrocardiograms of 26 Taiwanese patients with MPS III (five with IIIA, 20 with IIIB, and one with IIIC; 14 males and 12 females; median age, 7.4years; age range, 1.8-26.5years). The relationships between age and each echocardiographic parameter were analyzed.ResultsEchocardiographic examinations (n=26) revealed that 10 patients (38%) had valvular heart disease. Four (15%) and eight (31%) patients had valvular stenosis or regurgitation, respectively. The most prevalent cardiac valve abnormality was mitral regurgitation (31%), followed by aortic regurgitation (19%). However, most of the cases of valvular heart disease were mild. Three (12%), five (19%) and five (19%) patients had mitral valve prolapse, a thickened interventricular septum, and asymmetric septal hypertrophy, respectively. The severity of aortic regurgitation and the existence of valvular heart disease, aortic valve abnormalities and valvular stenosis were all positively correlated with increasing age (p<0.05). Z scores >2 were identified in 0, 38, 8, and 27% of left ventricular mass index, interventricular septal end-diastolic dimension, left ventricular posterior wall end-diastolic dimension, and aortic diameter, respectively. Electrocardiograms in 11 patients revealed the presence of sinus arrhythmia (n=3), sinus bradycardia (n=2), and sinus tachycardia (n=1). Six patients with MPS IIIB had follow-up echocardiographic data at 1.9-18.1years to compare with the baseline data, which showed some patients had increased thickness of the interventricular septum, as well as more patients had valvular abnormalities at follow-up.ConclusionsCardiac involvement in MPS III is less common and milder compared with other types of MPS. The existence of valvular heart disease, aortic valve abnormalities and valvular stenosis in the patients worsened with increasing age, reinforcing the concept of the progressive nature of this disease.
引用
收藏
页数:10
相关论文
共 46 条
  • [1] Early treatment with laronidase improves clinical outcomes in patients with attenuated MPS I: a retrospective case series analysis of nine sibships
    Al-Sannaa, Nouriya A.
    Bay, Luisa
    Barbouth, Deborah S.
    Benhayoun, Youssef
    Goizet, Cyril
    Guelbert, Norberto
    Jones, Simon A.
    Kyosen, Sandra Obikawa
    Martins, Ana Maria
    Phornphutkul, Chanika
    Reig, Celia
    Pleat, Rebecca
    Fallet, Shari
    Holder, Iva Ivanovska
    [J]. ORPHANET JOURNAL OF RARE DISEASES, 2015, 10
  • [2] Echocardiographic Assessment of Valve Stenosis: EAE/ASE Recommendations for Clinical Practice
    Baumgartner, Helmut
    Hung, Judy
    Bermejo, Javier
    Chambers, John B.
    Evangelista, Arturo
    Griffin, Brian P.
    Iung, Bernard
    Otto, Catherine M.
    Pellikka, Patricia A.
    Quinones, Miguel
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, 2009, 22 (01) : 1 - 23
  • [3] Aortic Root Dilatation in Mucopolysaccharidosis I-VII
    Bolourchi, Meena
    Renella, Pierangelo
    Wang, Raymond Y.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (12):
  • [4] Mucopolysaccharidosis: Cardiologic features and effects of enzyme-replacement therapy in 24 children with MPS I, II and VI
    Brands, Marion M. M. G.
    Frohn-Mulder, Ingrid M.
    Hagemans, Marloes L. C.
    Hop, Wim C. J.
    Oussoren, Esmee
    Helbing, Wim A.
    van der Ploeg, Ans T.
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 2013, 36 (02) : 227 - 234
  • [5] Cardiac issues in adults with the mucopolysaccharidoses: current knowledge and emerging needs
    Braunlin, Elizabeth
    Wang, Raymond
    [J]. HEART, 2016, 102 (16) : 1257 - 1262
  • [6] Cardiac findings after enzyme replacement therapy for mucopolysaccharidosis type I
    Braunlin, Elizabeth A.
    Berry, James M.
    Whitley, Chester B.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (03) : 416 - 418
  • [7] Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and management
    Braunlin, Elizabeth A.
    Harmatz, Paul R.
    Scarpa, Maurizio
    Furlanetto, Beatriz
    Kampmann, Christoph
    Loehr, James P.
    Ponder, Katherine P.
    Roberts, William C.
    Rosenfeld, Howard M.
    Giugliani, Roberto
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 2011, 34 (06) : 1183 - 1197
  • [8] Taiwan National Newborn Screening Program by Tandem Mass Spectrometry for Mucopolysaccharidoses Types I, II, and VI
    Chan, Min-Ju
    Liao, Hsuan-Chieh
    Gelb, Michael H.
    Chuang, Chih-Kuang
    Liu, Mei-Ying
    Chen, Hsiao-Jan
    Kao, Shu-Min
    Lin, Hsiang-Yu
    Huang, You-Hsin
    Kumar, Arun Babu
    Chennamaneni, Naveen Kumar
    Pendem, Nagendar
    Lin, Shuan-Pei
    Chiang, Chuan-Chi
    [J]. JOURNAL OF PEDIATRICS, 2019, 205 : 176 - 182
  • [9] Cardiovascular changes in mucopolysaccharidoses in Taiwan
    Chen, MR
    Lin, SP
    Hwang, HK
    Yu, CH
    [J]. ACTA CARDIOLOGICA, 2005, 60 (01) : 51 - 53
  • [10] Status of newborn screening and follow up investigations for Mucopolysaccharidoses I and II in Taiwan
    Chuang, Chih-Kuang
    Lin, Hsiang-Yu
    Wang, Tuan-Jen
    Huang, You-Hsin
    Chan, Min-Ju
    Liao, Hsuan-Chieh
    Lo, Yun-Ting
    Wang, Li-Yun
    Tu, Ru-Yi
    Fang, Yi-Ya
    Chen, Tzu-Lin
    Ho, Hui-Chen
    Chiang, Chuan-Chi
    Lin, Shuan-Pei
    [J]. ORPHANET JOURNAL OF RARE DISEASES, 2018, 13